Skip to main content
. Author manuscript; available in PMC: 2015 Mar 28.
Published in final edited form as: Cancer Lett. 2013 Nov 19;344(2):272–281. doi: 10.1016/j.canlet.2013.11.005

Figure 1. Activation of mTOR pathway in MCC tissues.

Figure 1

Representative positive immunohistochemical staining of P-4E-BP-1, P-S6K, P-mTOR, and MCV in sections from MCC TMA (left column). Representative negative immunohistochemical staining of P-4E-BP-1, P-S6K, P-mTOR, and MCV in sections from MCC TMA (right column)